// App-Quantinova.ai

1899 : Osteopontin and Leptin Are Associated with Erosive Disease in an Inception Cohort of Rheumatoid Arthritis Treated-to-Target with Combination Conventional DMARD Therapy

Researchers

Presenter

  • Mihir D. Wechalekar

Principal Investigators

  • Susan Lester

  • Sunil Nagpal

  • Suzanne Cole

  • Jessica Peters

  • Anuk Das

  • Pravin Hissaria

  • Tania Crotti

  • Catherine Hill

  • Sudha Raghunath

  • Llew Spargo

  • Jennifer G Walker

  • Malcolm D. Smith

  • Susanna Proudman

Medical Centers

  • Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia

  • Flinders University, Adelaide, Australia

  • Rheumatology Unit Repatriation, Queen Elizabeth Hospital, Adelaide, Australia

  • Queen Elizabeth Hospital, Adelaide, Australia

  • Immunology, Janssen Research and Development, Springhouse, PA

  • Immunology, Janssen Research and Development, Springhouse, PA

  • Janssen Research and Development, LLC, Spring House, PA

  • Janssen R&D, Berwyn, PA

  • Haematology Directorate, SA Pathology, Adelaide, Australia

  • University of Adelaide, Adelaide, Australia

  • School of Medicine, University of Adelaide, Adelaide, Australia

  • The Queen Elizabeth Hospital Campus, CALHN, Woodville, Australia

  • Repatriation General Hospital, Adelaide, Australia

  • Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia

  • University of South Australia, Adelaide, Australia

Locations

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Osteopontin

  • Leptin

  • Bone Mineral Density

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved